Skip to main content

Cannabis plants grow at an Organigram facility in Moncton on Oct. 12, 2019.John Morris/The Globe and Mail

Organigram Holdings Inc. said Tuesday it has acquired The Edibles & Infusions Corp. (EIC) in a $35-million stock deal, as the cannabis producer looks to tap surging demand for pot-based edibles and soft chews.

The U.S.-listed shares of Organigram were up 2 per cent at US$3.56 in premarket trade, after the Canadian company announced its deal with Vancouver-based pot firm AgraFlora Organics International Inc. , which owns 43 per cent of EIC.

Pot edibles, like gummy bears, brownies and drinks, have been the biggest beneficiaries of a demand windfall for cannabis-related companies during the pandemic, as consumers stuck at home spent more on their products.

“Edible products remain an important product category to Organigram, and EIC represents an ideal partner with which to expand our market presence in this category as well as other derivative cannabis categories,” Organigram chief executive Greg Engel said.

The deal comes on the heels of British American Tobacco announcing last month that it would buy a nearly 20-per-cent stake in Organigram for about £126-million ($219-million), as it looks to diversify beyond its main tobacco business.

Organigram said it currently expects first sales of EIC-manufactured soft chews in the fourth quarter of fiscal 2021.

The EIC deal has received approval from the Toronto Stock Exchange, the company said.

Hyperion Capital Inc. acted as exclusive financial adviser to Organigram and Goodmans LLP acted as legal adviser.

Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.